Update: A life of cognitive and physical exercise helps you stay sharp in your 70s and beyond

By SharpBrains | September 25, 2020

Wel­come to a new edi­tion of Sharp­Brains’ e‑newsletter, fea­tur­ing 13 fas­ci­nat­ing brain research find­ings, use­ful resources–and a brain teas­er to test your atten­tion skills. #1. Good news of the month: Elders today are in sig­nif­i­cant­ly bet­ter shape–physically and cognitively–than three decades ago #2. A dis­tinc­tion WITH a dif­fer­ence: Actu­al, sus­tained practice–not mere knowledge–is need­ed to…

Read More

Click Therapeutics and Boehringer Ingelheim partner to develop and market a digital therapeutic to treat schizophrenia

By SharpBrains | September 21, 2020

Boehringer Ingel­heim, Click Ther­a­peu­tics ink $500M+ dig­i­tal ther­a­peu­tics devel­op­ment, com­mer­cial­iza­tion deal (Mobi­Health­News): Inter­na­tion­al phar­ma Boehringer Ingel­heim and pre­scrip­tion dig­i­tal ther­a­peu­tics com­pa­ny Click Ther­a­peu­tics have inked a $500 mil­lion-plus deal to joint­ly devel­op and com­mer­cial­ize a dig­i­tal treat­ment for patients with schizophrenia.

Read More

Novartis dissolves agreement to market Pear Therapeutics’ prescription digital therapeutics for substance/ opioid abuse

By SharpBrains | October 25, 2019

_______________ As San­doz returns mar­ket­ing rights for dig­i­tal ther­a­peu­tics to Pear, what does it mean for co-pro­­mote arrange­ments? (MM&M): “San­doz, the gener­ics divi­sion of Novar­tis, is alter­ing com­mer­cial course, return­ing mar­ket­ing duties for two pre­scrip­tion dig­i­tal ther­a­peu­tics (DTx) back to Pear Ther­a­peu­tics. The move, which some had antic­i­pat­ed, comes 18 months after the two signed…

Read More

Update: Trained older brains can outperform untrained younger ones at demanding cognitive tasks

By SharpBrains | August 29, 2019

_______________ Time for Sharp­Brains e‑newsletter, fea­tur­ing the lat­est research, tools and think­ing for life­long brain health and men­tal well-being — and a cou­ple fun brain teasers :-) New brain research: Can trained old­er brains out­per­form untrained younger ones at demand­ing cog­ni­tive tasks? Quick answer: YES Sep­tem­ber 17th @ UC Berke­ley: Dis­rupt­ing neu­rode­gen­er­a­tive dis­eases New neu­rotech and…

Read More

Reinventing Brain Medicine, Pharma adopts Digital Therapeutics: Evidence-based videogames, smartphone apps, and sensors

By SharpBrains | March 19, 2018

___ From app store to drug store, dig­i­tal health is redefin­ing pharma’s pipeline (STAT): “The pitch­es always sound­ed promis­ing: A new soft­ware app could track glu­cose lev­els for peo­ple with dia­betes or soothe the brains of insom­ni­acs. Most phar­ma exec­u­tives would polite­ly smile and nod, but then park their mon­ey some­where else. Not anymore.

Read More

Trend: Taking health (and brain health) care “beyond the pill”

By SharpBrains | February 23, 2015

. How Device Mak­ers Can Take Health­care “Beyond the Pill” (Med­ical Device and Diag­nos­tic Indus­try): “One thing is clear: Pharma’s com­mit­ment to “beyond the pill” has nev­er been so appar­ent. Each and every phar­ma com­pa­ny seems to have formed a divi­sion or a strate­gic team to explore new ser­vices around patient com­pli­ance, pop­u­la­tion health data…

Read More